Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000107

COO and Secretary sold 10,000 shares at an average $52.84 ($528,404)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2021-11-04 Sale −6,717 $52.65 $353,650 466,366 I: show line 1 in the form
Schuth Alexander O. COO and Secretary 2021-11-04 Sale −3,283 $53.23 $174,754 463,083 I: show line 2 in the form
Open-market sales · 10,000 sh · avg $52.84 · $528,404
Loading xslF345X03/wf-form4_163640615125307.xml…